inter-batch variability? [Regulatives / Guidelines]

posted by Pavidus – 2010-08-04 13:57 (5450 d 01:41 ago) – Posting: # 5714
Views: 17,854

Dear Dr_Dan & all,

Allow me one general remark:
IMHO BE studies are definitely not suitable to assess inter-batch variability of any product.

I am not saying, that this remark will "save" your product .... discussion with 'assessors' is always difficult... :-(

(btw. nice figures for a highly-variable drug)

Kind regards, P.

Complete thread:

UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,676 registered users;
43 visitors (0 registered, 43 guests [including 8 identified bots]).
Forum time: 15:39 CEST (Europe/Vienna)

Many people tend to look at programming styles and languages like religions:
if you belong to one, you cannot belong to others.
But this analogy is another fallacy.    Niklaus Wirth

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5